UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
LIMNW holding history
Liminatus Pharma, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LIMNW overviewAll 13F holders of LIMNWFull Q2 2026 holdings
- Shares (Q2 2026)
- 4,507
- Value
- $338
- % of portfolio
- <0.1%
- Quarters held
- 5
- Since Q2 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 4,507 | $338 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 4,507 | $180 | <0.1% | +295+7.0% | Added | Holders |
| Q4 2025 | 4,212 | $147 | <0.1% | +3,922+1,352.4% | Added | Holders |
| Q3 2025 | 290 | $43 | <0.1% | −1,730−85.6% | Reduced | Holders |
| Q2 2025 | 2,020 | $485 | <0.1% | +2,020 | New | Holders |